Pharmaceutical

Silence announces $120m private placement for depositary shares

Silence Therapeutics has announced a private placement of its 5,714,286 American depositary shares (ADS) priced at $21 each.

Feb 6, 2024 - 18:00
Silence announces $120m private placement for depositary shares
Silence Therapeutics has announced a private placement of its 5,714,286 American depositary shares (ADS) priced at $21 each.
Read the original article

Tags:

Previous Article

Health Canada approves Chiesi’s MYALEPTA for lipodystrophy

Next Article

Incyte acquires global rights to MorphoSys’ tafasitamab

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Startup BioAge raises $170 million Series D for Zepbound combination therapy

STAT+: Startup BioAge raises $170 million Series D for ...

Feb 13, 2024

STAT+: Oracle Health chair says Cerner isn’t competing with Epic

STAT+: Oracle Health chair says Cerner isn’t competing ...

Mar 6, 2024

STAT+: Medtronic isn’t afraid of Wegovy’s potential to disrupt

STAT+: Medtronic isn’t afraid of Wegovy’s potential to ...

Nov 25, 2023